Skip to main content
. 2022 Apr 7;16(9):1436–1446. doi: 10.1093/ecco-jcc/jjac053

Table 4.

Trends in disease activity indices, CRP and faecal calprotectin over 12 months from baseline.

Variable, n. Baseline [BL] 3 months 6 months 12 months p-value BL vs 12 months
HBI, median [IQR] 1.0 [2.0], n = 110 0.0 [2.0], n = 89 0.0 [1.0], n = 82 0.0 [1.0], n = 78 0.104
SCCAI, median [IQR] 1.0 [3.0], n = 57 1.0 [3.0], n = 55 0.0 [2.8], n = 40 0.0 [4.0], n = 41 0.003
CRP mg/L, median [IQR] 4.0 [2.0], n = 178 2.0 [1.0], n = 159 1.0 [3.0], n = 141 2.0 [1.0], n = 132 0.008
FC, median µg/g [IQR] 67.5 [143.5], n = 102 56.0 [161.5], n = 126 67.5 [135.0], n = 118 79.0 [138.50, n = 117 0.207
Steroid use [%] 2 [1.1%] 1 [0.6%] 0 [0.0%] 0 [0.0%]

BL, baseline; n, number; CRP, C-reactive protein; HBI, Harvey-Bradshaw Index; IQR, interquartile range; SCCAI, Simple Clinical Colitis Activity Index; FC, faecal calprotectin.